Dr Reddys Laboratories (RDY) FCF Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded FCF Margin of 3.10% in the quarter ended Jun 30, 2026, down 22.05 percentage points from 25.15% a year earlier and down 17.72 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) FCF Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' FCF Margin came in at 15.24% as of Jun 30, 2026, down 4.74 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 23.91%, up 1.40 percentage points from the prior year.
- Annual FCF Margin has increased for four straight years, with a five-year change of +10.23 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, FCF Margin came in at 22.51% in the year ended Mar 31, 2025 (+0.36 pp), 22.15% in the year ended Mar 31, 2024 (+2.83 pp), 19.32% in the year ended Mar 31, 2023 (+13.05 pp) and 6.26% in the year ended Mar 31, 2022 (-7.42 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly FCF Margin since the quarter ended Jun 30, 2021.
- On a year-over-year basis, FCF Margin rose in four of the last eight quarters, with an average year-over-year change of -1.48 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 23.31 percentage points in the quarter ended Dec 31, 2021, against a drop of 23.05 percentage points in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 20.82% (quarter ended Mar 31, 2026), 12.50% (quarter ended Dec 31, 2025) and 23.62% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 3.10% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.10% |
| Mar 31, 2026 | 20.82% |
| Dec 31, 2025 | 12.50% |
| Sep 30, 2025 | 23.62% |
| Jun 30, 2025 | 25.15% |
| Mar 31, 2025 | 25.86% |
| Dec 31, 2024 | 7.92% |
| Sep 30, 2024 | 21.02% |
| Jun 30, 2024 | 17.73% |
| Mar 31, 2024 | 8.81% |
| Dec 31, 2023 | 13.89% |
| Sep 30, 2023 | 31.41% |
| Jun 30, 2023 | 21.89% |
| Mar 31, 2023 | 29.52% |
| Dec 31, 2022 | 36.94% |
| Sep 30, 2022 | 14.13% |
| Jun 30, 2022 | 12.76% |
| Mar 31, 2022 | 16.77% |
| Dec 31, 2021 | 32.26% |
| Sep 30, 2021 | 9.83% |
Dr Reddys Laboratories FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();